Last reviewed · How we verify
NCT03658278
Trauma Screening and Supplementation
NA trial testing Juven in Trauma in 400 participants. Completed in 13 November 2019.
13 November 2019
Quick facts
| Lead sponsor | Michael C Willey |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 400 |
| Start date | 15 March 2018 |
| Primary completion | 13 November 2019 |
| Estimated completion | 13 November 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Juven — full drug profile →
Conditions studied
- Trauma — all drugs for Trauma →
- Nutritional Deficiency — all drugs for Nutritional Deficiency →
- Wound Heal — all drugs for Wound Heal →
Sponsor
Michael C Willey
Who can join
Adults 18 to 100, any sex, with Trauma or Nutritional Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the proposed study is twofold: 1) The investigators will evaluate ultrasound imaging to screen trauma patients to identify patients at increased risk of postoperative complications associated with sarcopenia. 2) The investigators will evaluate a commercially-available oral nutritional supplement that has previously been evaluated in critically-ill intensive care patients and shown benefit for decreasing complications including decreased wound healing complications, decreased pressure ulcers, decreased skeletal muscle loss due to immobilization, and decreased one-year mortality.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Nutritional interventions for preventing and treating pressure ulcers.
Langer G, Wan CS, Fink A, Schwingshackl L, et al · · 2024 · cited 20× · PMID 38345088 · DOI 10.1002/14651858.cd003216.pub3
Verify or expand the search:
- PubMed search for NCT03658278
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Juven
Trials testing the same drug.
- NCT05971173 — Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery · EARLY_PHASE1 · completed
Other recruiting trials for Trauma
Currently open trials in the same condition.
- NCT07290634 — Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion · recruiting
- NCT07485231 — Nitric Oxide (NO) and Endothelial Dysfunction in Women With PTSD · NA · recruiting
- NCT07473336 — The Effectiveness of RAPID-Based Psychological First Aid Training · NA · active not recruiting
- NCT07278505 — Study of Cannabidiol and Neuroimaging on Stress · Phase 1, PHASE2 · recruiting
- NCT02880163 — REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam · NA · recruiting
Other Michael C Willey trials
Trials by the same sponsor.
- NCT04039386 — Psychosocial Interventions for Young Adults With Hip Pain · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03658278 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Michael C Willey
- Last refreshed: 21 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03658278.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing